| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-15 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-14 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-14 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-13 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-12 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-12 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.21 | 5e-11 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-11 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.23 | 8e-11 |